Conceptually, a wide beneficial effect, both peripherally and centrally, might have been
essential for the harmony of brain–gut and gut–brain axes' function. Seen from the original …

We highlight the particular aspects of the stable gastric pentadecapeptide BPC 157
pleiotropic beneficial activity (not destroyed in human gastric juice, native and stable in …

First, we review the definitively severed myotendinous junction and recovery by the
cytoprotective stable gastric pentadecapeptide BPC 157 therapy, its healing that might …

Since the early 1990s, when Robert's and Szabo's cytoprotection concept had already been
more than one decade old, but still not implemented in therapy, we suggest the stable …

BACKGROUND Using rat stomach perforation as a prototypic direct lesion applied in
cytoprotection research, we focused on the first demonstration of the severe …

Even before behavioral disturbances, neuroleptics, amphetamine, and domperidone
application rapidly emerged severe occlusion/occlusion-like syndrome, shared innate …

We focused on the first demonstration that antiarrhythmics, particularly class II and class III
antiarrhythmic and beta-blocker sotalol can induce severe occlusion/occlusion-like …

After inferior caval vein embolization therapy, post-embolization syndrome (sodium laurate
10 mg/kg, 0.1 mL into rat inferior caval vein, assessment at 15, 30, 60 min, prime lung …

Given in reperfusion, the use of stable gastric pentadecapeptide BPC 157 is an effective
therapy in rats. It strongly counteracted, as a whole, decompression/reperfusion-induced …

Recently, stable gastric pentadecapeptide BPC 157 therapy by activation of collateral
pathways counteracted various occlusion/occlusion-like syndromes, vascular, and …